ERA-NET ON TRANSLATIONAL CANCER RESEARCH (TRANSCAN-2) –“Translational research on rare cancers””
- Entidad convocante:
- European Commission
- Categoría:
- Projectes de recerca
- Ámbito:
- Internacional
- Inicio:
- Plazo interno:
- Plazo real:
- Descripción:
-
Objectiu de la convocatòria
TRANSCAN-2 has the goal of coordinating national and regional funding programmes for research in the area of translational cancer research. The specific challenge is to promote a transnational collaborative approach between scientific teams in demanding areas of translational cancer research while avoiding the duplication of efforts and ensuring a more efficient use of available resources, to produce significant results of higher quality and impact, and share data and infrastructures.
The EC co-funded call of TRANSCAN-2 (JTC 2017) will focus on: "Translational research on rare cancers".Característiques principals
The proposals of the present call will have to cover a minimum of one of the specific aims reported below:- Aim 1: Design and conduct of translational research studies exploiting/combining resources from current clinical trials, bio-repositories and epidemiology-type resources.
- Aim 2: Development and exploitation of translational research platforms (e.g., patient derived xenograft models/organoids/tissue collections) to study drug responses/resistance and toxicity, and perform drug screens or repurpose approved anticancer drugs.
- Aim 3: Implementation of precision biomarkers for better stratification of the clinical cohorts.
Requisits
Only transnational projects will be funded. Each research consortium must involve a minimum of three (3) research groups and a maximum of seven (7) research groups. The groups must be from at least three (3) different countries participating in the call. In addition, a consortium must not involve more than two (2) research groups from one country (in such cases the minimum number of groups must be 4, coming from 3 different countries). The maximum number of 7 research groups could be increased only with partners from the following countries : Estonia, Latvia, Slovakia and Turkey, up to a maximum of 4 additional partners from the 4 countries, to reach a maximum total of 11 research groups in a proposal.
In order to strengthen the European translational cancer research area, a wide inclusion of research teams from all the countries/regions participating in the call is encouraged, with a particular attention to research teams from Estonia, Latvia, Slovakia and Turkey.
Each consortium must involve at least one basic or pre-clinical research team and one clinical team.
Plase check the Call Text for detailed eligibility rules.
For Spanish applicants: please check the eligibility requirements of the institution and the principal investigator/team members, in pages 56-59 of the Call Text.Dotació
For Spanish participants:- up to 150,000 € (overheads included) per partner
- up to 200.000 € (overheads included) per coordinator
Durada
3 years
Convocatòria (URL)
http://www.transcanfp7.eu/index.php/calls/fourth-joint-transnational-call-jtc-2017.html